Florida Board will Revisit Franck's Lab and Anazao Health Corp cases at Dec. 11-12th meeting

Here is a summary:

A. Chair's Report - Cynthia Griffin, PharmD, Chair
1. Dr. Cynthia Griffin – Short Term Priority List
a. Emergency Rule
b. Re-visit Cases with Sterile Compounding Issues
i.
Franck’s Lab, Inc d/b/a Franck’s Compounding Pharmacy
ii.
Anazao Health Corp
c. Inspector Training
d. Non-Resident Pharmacies Compliance with Florida Law
e. Possible Requirement of FL Pharmacist in Non-Resident Pharmacy
f. USP Standards – Physician Exemptiong. Collaboration with other Professional Boards
h. Proposed Legislation
i. Disciplinary Guidelines
2. Dr. Michele Weizer
a. USP 797 Beyond Use Date (BUD)

To view complete agenda click here